A GIST light trial reported lower self-rated insomnia scores. Mixed sleep measurements and open safety questions keep the findings preliminary.
On September 24, 2026, Seoul Economic Daily reported that GIST researchers had tested near-infrared light in a preliminary sleep trial and recorded lower self-assessed insomnia and sleep-quality scores in the active group.
The central finding concerns how participants rated their sleep problems. According to Seoul Economic Daily, the active group's Insomnia Severity Index (ISI) scores fell 26%. Its Pittsburgh Sleep Quality Index (PSQI) scores fell 29.6%.
Both figures describe self-assessed outcomes. The ISI result concerns insomnia severity, while the PSQI result concerns sleep quality. These are the findings behind the attention the trial received.
For a midlife adult who feels tired or struggles to settle at night, reports of improvement deserve a careful reading. Feeling better matters. The useful question is exactly what changed and how the researchers assessed that change.
A questionnaire result addresses participants' reported experience. A recorded sleep measure addresses another part of the picture. Keeping those categories separate helps readers understand a study without asking a single percentage to explain the whole experience of sleep and recovery.
That distinction also provides useful context for reading sleep scores alongside everyday sleep problems. The goal is not to dismiss a person's assessment or treat a device reading as the only result that matters. It is to understand the contribution of each measure.
A separate report on the study focused on the proposed connection between near-infrared light and a brain chemical involved in sleep. Seoul Economic Daily placed the work within interest in non-drug approaches to sleep management.
That gives the research a biological question alongside its clinical question. Researchers are investigating a possible pathway while also asking whether participants experience a useful change. For readers, the clinical question remains the most relevant: does the tested approach make a dependable difference to sleep and daily life?
GIST professor Tae Kim said the preliminary trial showed “the potential for improvement” in participants' insomnia symptoms and sleep quality, according to Seoul Economic Daily. That wording fits an early research signal rather than an established treatment.
The percentages need careful interpretation. They are decreases in scores within the stimulation group, not equivalent percentage increases in sleep itself. They should not be read as showing that participants slept 26% longer or that the device improved sleep quality by 29.6% compared with control.
The same report also described a less favorable finding: overall wrist-worn-device sleep measurements showed no clear difference between the active and control groups. The reported improvement in participants' assessments therefore did not have a clear matching result across those overall recorded measures.
Neither finding should erase the other. The self-assessed results give researchers something worth investigating. The wrist-device results limit how confidently the study can be presented as evidence of improved sleep across different kinds of measurement.
Long-term safety and effectiveness also remain unsettled. Seoul Economic Daily reported that Tae Kim's team plans to assess objective sleep effects and long-term safety in a larger group. The findings need replication and follow-up before they can support broader conclusions.
GIST professor Jae Gwan Kim said wavelength, light intensity, duration and timing need further investigation. Those are study conditions for researchers to define, not settings for readers to reconstruct from a news story. Results from a specific prototype do not establish that consumer light devices or unsupervised home use treat insomnia.
The study used non-commercial prototype devices supplied by TEDi MEDi, which was co-founded by two of the study's professors. That company relationship belongs alongside the findings when evaluating the work. It is a reason to look closely at the methods and future independent testing, not a reason by itself to dismiss the results.
Taken together, these points set a clear boundary around the report. It is an early finding with encouraging participant assessments and mixed measurement results. It is not a basis for replacing professional assessment or established care.
For adults aged 35 to 65, the useful daily habit is a brief evidence check when a sleep-technology claim appears. Before treating a headline as a purchasing decision, identify what was measured and what comparison supports the claim. This trial supports that pause rather than a new home light routine.
Start with the words attached to the number. In this case, the reported changes concern self-assessed questionnaire scores. Keeping that description attached to the percentage prevents a report about symptom ratings from becoming a much broader promise about sleep.
Useful questions for future coverage include:
These questions come directly from the gaps the researchers and reporting identify. They are a way to judge the next piece of evidence, not a checklist for operating a device.
There is no need to turn this into an elaborate research project. A practical reading habit is simply to distinguish “people reported lower symptom scores” from “the treatment produced a demonstrated advantage over control.” Those statements carry different meanings and should lead to different levels of confidence.
If sleep difficulties persist or interfere with daytime functioning, a conversation with a qualified health professional is more useful than treating this trial as a substitute for assessment. Questions about personal care need more context than a report about an investigational prototype can provide.
The same applies when someone already has a care plan. A promising technology headline is something to discuss, not evidence on its own that current care should be replaced. The practical priority is the ongoing sleep problem and its effect on daily life.
For readers whose efforts have become a cycle of adding another habit or product, looking beyond another round of sleep-habit advice offers a more relevant direction for further reading. Interest in research can sit alongside seeking appropriate help rather than postponing it.
A question about this prototype is also different from the everyday question of how light fits into a sleep schedule. When reading about either subject, keep the purpose of the information clear: understanding an experimental technology is not the same task as understanding a daily routine.
Readers sorting through those broader issues can use Relaxopia's coverage of light exposure and sleep timing as separate background. Keeping the questions distinct makes it easier to discuss them clearly and avoids turning one trial into a general rule about light.
The manageable adjustment is therefore an information habit: identify the outcome, check the comparison and keep personal care decisions with qualified support. No device purchase or self-administered exposure schedule is needed to put that habit into practice.
The next stage of this research is not simply about producing a more striking headline. Its value will depend on whether the technology earns a clear role in helping people with sleep difficulties. For midlife adults, that role would need to make sense alongside ordinary responsibilities rather than add another demanding recovery task.
A useful long-term approach should be understandable enough for people to discuss with their care team. It should also keep the focus on the person's sleep and functioning rather than on the novelty of the equipment.
If stronger evidence emerges, could near-infrared technology become a useful part of long-term midlife recovery without turning rest into another complicated routine?
Day-to-day light and sleep-timing choices sit with the adult managing the routine; Relaxopia brings a research-led perspective to those decisions. For adults 35+ weighing unfamiliar device claims, its coverage connects questions about circadian rhythm with sleep quality and recovery through clear explanations rather than rigid protocols or technical complexity.
Stay connected for research-led guidance on sleep quality, stress, circadian rhythm, recovery, fatigue and everyday energy. Clear ideas for adults 35+ who want to sleep better, recover more fully and feel more capable through the day.
Explore practical guidance on sleep, stress and recovery without chasing every new hack, device or promise.
explore the blog